Papillomavirus-like particles and HPV vaccine development

By Schiller J.T.   Lowy D.R.  

Seminars in Cancer Biology, Vol. 7, Iss. 6, 1996-12 ,pp. : 373-382

Academic Press

Access to resources Recommend Favorite

Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein–based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia

By Hallez Sophie   Simon Philippe   Maudoux Frédéric   Doyen Jean   Noël Jean-Christophe   Beliard Aude   Capelle Xavier   Buxant Frédéric   Fayt Isabelle   Lagrost Anne-Cécile   Hubert Pascale   Gerday Colette   Burny Arsène   Boniver Jacques   Foidart Jean-Michel   Delvenne Philippe   Jacobs Nathalie  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 7, 2004-07 ,pp. : 642-650

Springer Publishing Company

Access to resources Recommend Favorite

Human papillomavirus vaccine: knowledge and attitudes in two Appalachian Kentucky counties

By Hopenhayn Claudia   Christian Amy   Christian W.   Schoenberg Nancy  

Cancer Causes and Control, Vol. 18, Iss. 6, 2007-08 ,pp. : 627-634

Springer Publishing Company

Access to resources Recommend Favorite

Do ''High-Risk'' Human Papillomavirus (HPV) Types Lead to Cancer by Evading the Immune System?

By Tendler A.   Ho G.Y.F.   Kadish A.S.  

Gynecologic Oncology, Vol. 73, Iss. 1, 1999-04 ,pp. : 169-170

Elsevier

Access to resources Recommend Favorite

Chitosan as an adjuvant for a Helicobacter pylori therapeutic vaccine

By                  

Molecular Medicine Reports, Vol. 12, Iss. 3, 2015-01 ,pp. : 4123-4132

Spandidos Publications

Access to resources Recommend Favorite